Category: SFA

Chocolate Touch drug-coated angioplasty balloon for treatment of PAD receives FDA approval

Genesis MedTech Group announced that the US Food and Drug Administration (FDA) has approved the Chocolate Touch drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter, developed by TriReme Medical, for the treatment of patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA) and the popliteal artery.  The Chocolate Touch DCB was shown […]

The post Chocolate Touch drug-coated angioplasty balloon for treatment of PAD receives FDA approval appeared first on Vascular News.

Endologix submits premarket approval application to FDA for Detour system

Endologix has announced the submission of a premarket approval (PMA) application requesting approval for the Detour system to the US Food and Drug Administration (FDA). The Detour system, which earned FDA Breakthrough Device Designation, is a unique therapy that allows the creation of a fully percutaneous femoropopliteal bypass that is routed through the femoral vein. […]

The post Endologix submits premarket approval application to FDA for Detour system appeared first on Vascular News.